miralax

2
NURS 1566 Clinical Form 3: Clinical Medications Worksheets (You will need to make additional copies of these forms) Generic Name polyethylen e glycol Trade Name MiraLax Classification Therapeutic: laxatives Pharmacologic: osmotics Dose 17g in 8 oz liquid Route PO Time/ frequency Once/ Now Peak 2-4 days Onset Unknown Duration Unknown Normal dosage range 17g. (One heaping teaspoon) in 8 oz. of water may be used for up to two weeks Why is your patient getting this medication Constipation For IV meds, compatibility with IV drips and/or solutions N/A Mechanism of action and indications (Why med ordered) Acts as an osmotic agent, drawing water into the lumen of the GI tract. Indicated for evacuation of the GI tract without water or electrolyte imbalance. Nursing Implications (what to focus on) Contraindications/warnings/interactions GI obstruction, Gastric retention, Toxic colitis, Megacolon/ Use cautiously in Abdominal pain of uncertain cause, particularly if accompanied by fever/ No significant interactions Common side effects abdominal bloating, cramping, flatulence, nausea, Interactions with other patient drugs, OTC or herbal medicines (ask patient specifically) none Lab value alterations caused by medicine None found Be sure to teach the patient the following about this medication Inform patient that 2-4 days may be required to produce a bowel movement. PEG should not be used for more than 2 wk. Prolonged, frequent, or excessive use may result in electrolyte imbalance and laxative dependence. Advise patient to notify health care professional if unusual cramps, bloating, or diarrhea occurs Nursing Process- Assessment (Pre-administration assessment) Assess patient for abdominal distention, presence of bowel sounds, and usual pattern of bowel function Assessment Why would you hold or not give this med? Diarrhea, obstruction Evaluation Check after giving A soft, formed bowel movement

Upload: cassie

Post on 11-Apr-2015

1.257 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: MiraLax

NURS 1566 Clinical Form 3: Clinical Medications Worksheets(You will need to make additional copies of these forms)

Generic Namepolyethylene glycol

Trade NameMiraLax

ClassificationTherapeutic: laxativesPharmacologic: osmotics

Dose17g in 8 oz liquid

RoutePO

Time/frequencyOnce/ Now

Peak2-4 days

OnsetUnknown

DurationUnknown

Normal dosage range17g. (One heaping teaspoon) in 8 oz. of water may be used for up to two weeks

Why is your patient getting this medicationConstipation

For IV meds, compatibility with IV drips and/or solutionsN/A

Mechanism of action and indications(Why med ordered)Acts as an osmotic agent, drawing water into the lumen of the GI tract. Indicated for evacuation of the GI tract without water or electrolyte imbalance.

Nursing Implications (what to focus on) Contraindications/warnings/interactions GI obstruction, Gastric retention, Toxic colitis, Megacolon/ Use cautiously in Abdominal pain of uncertain cause, particularly if accompanied by fever/ No significant interactions

Common side effectsabdominal bloating, cramping, flatulence, nausea,

Interactions with other patient drugs, OTC or herbal medicines (ask patient specifically)none

Lab value alterations caused by medicineNone found

Be sure to teach the patient the following about this medicationInform patient that 2-4 days may be required to produce a bowel movement. PEG should not be used for more than 2 wk. Prolonged, frequent, or excessive use may result in electrolyte imbalance and laxative dependence. Advise patient to notify health care professional if unusual cramps, bloating, or diarrhea occurs

Nursing Process- Assessment(Pre-administration assessment)Assess patient for abdominal distention, presence of bowel sounds, and usual pattern of bowel function

AssessmentWhy would you hold or not give this med?Diarrhea, obstruction

EvaluationCheck after givingA soft, formed bowel movement